A dedicated fund for European science
Europe’s research is world-class and under-capitalized at the earliest stage. We built a dedicated fund to meet it there.
Our European team works with leading scientists and research institutions to build companies from that science, on the same thesis and with the same underwriting as our US work. Founders get direct access to Tachyon’s US network of investors, partners and experts: a transatlantic path from the lab to a global company.
The same thesis, the same underwriting, on the continent’s best science.
The shift it rides
Causal target biology, design-to-spec, or a delivery unlock.
World-class science
Research at the forefront of biology, medicine and bioengineering.
Protected IP
Intellectual property strong enough to support a differentiated company.
Global ambition
European science with the potential to build a globally important company.
Building a biotech company in Europe?
We back European science from company formation. Talk to our European team.